Cargando…
Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
BACKGROUND: Studies have shown that the regulation of ferroptosis could be a new approach to cancer treatment and abnormal ferroptosis is closely associated with a dysregulated immune response. However, a combined signature with ferroptosis-related genes (FRGs) and immune-related genes (IRGs) is nec...
Autores principales: | Li, Han, Ge, You, Fei, Gaoqiang, Wang, Zemin, Wang, Shuai, Wei, Pingmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641098/ https://www.ncbi.nlm.nih.gov/pubmed/36388044 http://dx.doi.org/10.21037/tcr-22-992 |
Ejemplares similares
-
Identification and validation of a genomic mutation signature as a predictor for immunotherapy in NSCLC
por: Wang, Zemin, et al.
Publicado: (2022) -
Epidemiological trends and incidence prediction of lung cancer in China based on the Global Burden of Disease study 2019
por: Li, Han, et al.
Publicado: (2022) -
Serum vitamin D levels and Sjogren’s syndrome: bi-directional Mendelian randomization analysis
por: Zhao, Meng, et al.
Publicado: (2023) -
Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
por: Yang, Li, et al.
Publicado: (2023) -
Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis
por: Ren, Ziyuan, et al.
Publicado: (2021)